2024
|
Invention
|
Highly pure phentolamine mesylate and methods for making same.
This invention provides methods f... |
|
Invention
|
Gene therapy for ocular disease. Methods and compositions for gene therapy of retinal degeneratio... |
2023
|
Invention
|
Aqueous ophthalmic solutions of phentolamine and medical uses thereof.
The invention provides aq... |
|
Invention
|
Methods and compositions for daily ophthalmic administration of phentolamine to improve visual pe... |
2022
|
Invention
|
Highly pure phentolamine mesylate. This invention provides methods for synthesizing phentolamine ... |
|
Invention
|
Methods and compositions for treatment of mydriasis. The invention provides methods, compositions... |
|
Invention
|
Highly pure phentolamine mesylate and methods for making same. This invention provides methods fo... |
|
Invention
|
Methods and compositions for treating mydriasis, glaucoma, and other ocularconditions.
The inven... |
|
Invention
|
Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders. The ... |
|
G/S
|
pharmaceutical and biologic preparations for the diagnosis and treatment of retinal and ocular di... |
|
G/S
|
research and development services in the field of retinal and ocular diseases; research and devel... |
2021
|
Invention
|
Aqueous ophthalmic solutions of phentolamine and medical uses thereof. The invention provides aqu... |
|
Invention
|
Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders.
The... |
2019
|
Invention
|
Methods and compositions for treatment of glaucoma and related conditions. Methods, compositions ... |